MedTrace Logo

Stellate Ganglion Block

NCT06271707 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-09-04

No results posted yet for this study

Summary

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

Conditions

  • Esophagectomy
  • Pneumonectomy
  • Lobectomy

Interventions

DRUG

0.5% bupivacaine

an ultrasound guided left stellate ganglion block with 5 mL of 0.5% bupivacaine

OTHER

Saline

an ultrasound guided left stellate ganglion block with 5 mL of saline

Sponsors & Collaborators

Principal Investigators

  • Jacob Hutchins · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-19
Primary Completion
2027-04-15
Completion
2027-07-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06271707 on ClinicalTrials.gov